NCT05265624View on ClinicalTrials.gov

The Moran AMD Genetic Testing Assessment Study

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

July 12, 2024

Study Completion Date

July 12, 2024

Conditions
Age-Related Macular DegenerationGenetic TestingNutritional Biomarkers
Interventions
BEHAVIORAL

Early disclosure of genetic testing results

Early disclosure group receives results of genetic testing at Month 1

BEHAVIORAL

Late disclosure of genetic testing results

Late disclosure group receives results of genetic testing at Month 12

Trial Locations (1)

84132

University of Utah John A. Moran Eye Center, Salt Lake City

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Paul S. Bernstein

OTHER